ClinVar Miner

Submissions for variant NM_006623.4(PHGDH):c.418G>A (p.Gly140Arg)

dbSNP: rs587777770
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV002514704 SCV003523348 uncertain significance PHGDH deficiency 2022-07-04 criteria provided, single submitter clinical testing In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 140 of the PHGDH protein (p.Gly140Arg). This variant is present in population databases (rs587777770, gnomAD 0.007%). This missense change has been observed in individual(s) with Neu-Laxova syndrome (PMID: 24836451, 26960553). ClinVar contains an entry for this variant (Variation ID: 139534). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0").
Genomic Medicine Center of Excellence, King Faisal Specialist Hospital and Research Centre RCV002514704 SCV004801211 likely pathogenic PHGDH deficiency 2024-03-14 criteria provided, single submitter research
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV002514704 SCV005887734 pathogenic PHGDH deficiency 2025-01-21 criteria provided, single submitter clinical testing Variant summary: PHGDH c.418G>A (p.Gly140Arg) results in a non-conservative amino acid change located in the D-isomer specific 2-hydroxyacid dehydrogenase, NAD binding domain (IPR006140) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4e-06 in 251474 control chromosomes. c.418G>A has been reported in the literature in multiple homozygous individuals affected with clinical features of Phosphoglycerate Dehydrogenase Deficiency (Shaheen_2014, El-Hattab_2016). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 26960553, 24836451, 30214071). ClinVar contains an entry for this variant (Variation ID: 139534). Based on the evidence outlined above, the variant was classified as pathogenic.
OMIM RCV000128433 SCV000172114 pathogenic Neu-Laxova syndrome 1 2014-06-05 no assertion criteria provided literature only
Genomic Medicine Center of Excellence, King Faisal Specialist Hospital and Research Centre RCV000171157 SCV000221353 likely pathogenic not provided flagged submission research

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.